You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 71 Issue 5

Special Issue: Drug allergy: themed section

May 2011

Volume 71, Issue 5

Pages 637–800

  1. Editors' view

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      Allergy, pseudo-allergy and non-allergy (pages 637–638)

      Derek G. Waller

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2011.03976.x

  2. New drug mechanisms

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      Rilonacept and canakinumab (pages 639–641)

      Eline A. Dubois, Robert Rissmann and Adam F. Cohen

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2011.03958.x

      • image
      • image
  3. Drug allergy: themed section

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
    2. You have free access to this content
      Peri-operative anaphylaxis (pages 647–658)

      Linda Nel and Efrem Eren

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2011.03913.x

    3. You have free access to this content
      Hypersensitivity reactions to HIV therapy (pages 659–671)

      Mas Chaponda and Munir Pirmohamed

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03784.x

      • image
      • image
    4. You have free access to this content
      Skin manifestations of drug allergy (pages 672–683)

      Michael R. Ardern-Jones and Peter S. Friedmann

      Version of Record online: 6 MAY 2010 | DOI: 10.1111/j.1365-2125.2010.03703.x

      • image
      • image
      • image
    5. You have free access to this content
      Epidemiology and risk factors for drug allergy (pages 684–700)

      Bernard Y-H. Thong and Teck-Choon Tan

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03774.x

    6. You have free access to this content
      Delayed drug hypersensitivity: models of T-cell stimulation (pages 701–707)

      Jacqueline Adam, Werner J. Pichler and Daniel Yerly

      Version of Record online: 28 JUL 2010 | DOI: 10.1111/j.1365-2125.2010.03764.x

      • image
  4. Pharmacodynamics

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men (pages 708–717)

      Bart J. Van der Schueren, Rebecca Blanchard, M. Gail Murphy, John Palcza, Inge De Lepeleire, Anne Van Hecken, Marleen Depré and Jan N. de Hoon

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03869.x

      • image
      • image
      • image
  5. Drug interactions

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren (pages 718–726)

      Tuija Tapaninen, Pertti J. Neuvonen and Mikko Niemi

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03898.x

      • image
      • image
      • image
      • image
    2. You have free access to this content
      Perpetrators of pharmacokinetic drug–drug interactions arising from altered cytochrome P450 activity: a criteria-based assessment (pages 727–736)

      Thomas M. Polasek, Frank P. Y. Lin, John O. Miners and Matthew P. Doogue

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2011.03903.x

      • image
  6. Pharmacogenetics

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients (pages 737–750)

      Joanne S. L. Lim, Xiang A. Chen, Onkar Singh, Yoon S. Yap, Raymond C. H. Ng, Nan S. Wong, Mabel Wong, Edmund J. D. Lee and Balram Chowbay

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2011.03905.x

      • image
      • image
  7. Paediatric clinical pharmacology

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
  8. Drug safety

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      Cannabis-related hospitalizations: unexpected serious events identified through hospital databases (pages 758–765)

      Emilie Jouanjus, Florence Leymarie, Marie Tubery and Maryse Lapeyre-Mestre

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03897.x

      • image
  9. Pharmacoepidemiology

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      Statin adherence and the risk of major coronary events in patients with diabetes: a nested case–control study (pages 766–776)

      Päivi Ruokoniemi, Maarit J. Korhonen, Arja Helin-Salmivaara, Piia Lavikainen, Antti Jula, Seppo Y. T. Junnila, Raimo Kettunen and Risto Huupponen

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03895.x

      • image
  10. Short reports

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      Reversible posterior leucoencephalopathy syndrome in an elderly male on sunitinib therapy (pages 777–779)

      Biswa M. Padhy, Saravana P. Shanmugam, Yogendra K. Gupta and Aman Goyal

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03893.x

    2. You have free access to this content
      Outcomes of a decision support prompt in community pharmacy-dispensing software to promote step-down of proton pump inhibitor therapy (pages 780–784)

      Colin Curtain, Gregory M. Peterson, Peter Tenni, Ivan K. Bindoff and Mackenzie Williams

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03890.x

      • image
  11. Letters to the editors

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      What's in a name? (pages 785–786)

      Geoffrey T. Tucker and John O. Miners

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2010.03817.x

    2. You have free access to this content
      Integrating pharmacology and clinical pharmacology (pages 787–790)

      Jeffrey K. Aronson

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2011.03910.x

  12. Book review

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
  13. Mandarin translations section

    1. Top of page
    2. Editors' view
    3. New drug mechanisms
    4. Drug allergy: themed section
    5. Pharmacodynamics
    6. Drug interactions
    7. Pharmacogenetics
    8. Paediatric clinical pharmacology
    9. Drug safety
    10. Pharmacoepidemiology
    11. Short reports
    12. Letters to the editors
    13. Book review
    14. Mandarin translations section
    1. You have free access to this content
      Translation Section (pages 793–800)

      Version of Record online: 11 APR 2011 | DOI: 10.1111/j.1365-2125.2011.03971.x

SEARCH

SEARCH BY CITATION